GLI GLI Quality Tool
GLI Quality Tool — Version 2.0

A lean TB laboratory method to reduce repeat smear tests

Creating a TB lab lean management method for reducing repeat smear tests due to poor collection starts with a useful distinction: a repeat may be clinically necessary, or it may be avoidable rework. In many services, weak sputum quality, unclear instructions, delayed transport, and incomplete rejection feedback force patients to return while another slide, reagent set, and staff hour are consumed. This waste is measurable but often hidden in routine microscopy workload.

A lean laboratory workflow treats these events as process defects rather than blaming patients or operators. The team maps each step, defines a reliable standard, removes waiting and duplication, and checks whether the change lowers invalid or inadequate repeats. Clinical judgement remains central: fewer avoidable repeats must never mean fewer specimens when diagnosis or monitoring still requires them.

The GLI Quality Tool offers a practical backbone through its four-phase roadmap, phase-specific checklists, user instructions, and downloadable materials. Organised around twelve Quality Systems Essentials, it helps laboratories connect daily tuberculosis testing work with safety, personnel, equipment, documentation, assessment, and continual improvement. The lean method described here fits within that structure, so each local change is traceable to a quality objective and can be reviewed rather than left as informal good practice.

For Australian teams, the method must fit metropolitan hospitals, private pathology providers, regional services, and remote clinics. Melbourne and Sydney laboratories may run high volumes across shifts, while services around Darwin, Alice Springs, and Perth can face long transport links and limited staffing. Collection kits available through Australian suppliers can support consistency, but movement of imported or preserved specimens should be checked against Australian Customs and Department of Agriculture, Fisheries and Forestry biosecurity requirements.

Find the causes hidden in repeat testing

Start with a short review of repeat and rejected specimens from the previous four to eight weeks. Record the stated reason, collection site, time to receipt, staff involved, and whether another sample was actually required. Compare this baseline with workload and staffing. A Pareto chart usually shows whether a few causes dominate, while a brief process map reveals where information or specimens wait.

Current signal Likely failure point Lean response
Saliva, food, or blood visible Preparation and collection coaching Standard patient script and supervised expectoration
Consistently low specimen volume Technique or unsuitable container Demonstrated competency and fit-for-purpose kit
Correct label but long delay Transport or access bottleneck Scheduled runs with defined handover points
Repeat ordered after vague rejection Missing feedback loop Mandatory reason codes and timely advice
Several kits used for one patient Stock and labelling inconsistency One kit per encounter with controlled replenishment

Distinguish an inadequate sample from a valid negative result. Saliva is not equivalent to sputum, yet a laboratory may still need to process the specimen under policy. The improvement target is the rate of first-pass acceptable sputum, not a quota for rejecting specimens. Use the comparison to select one measurable failure mode, such as late access in rural clinics or unclear coaching during evening collection, before changing the whole workflow.

Standardise collection at the point of care

Write collection as standard work that any trained staff member can follow. Include a plain-language preparation instruction, observation of effort and sputum quality, the approved container, immediate labelling, and what to do when no specimen is produced. Train through observed demonstrations rather than a reading pack, covering identity checks, coaching expectoration, sealing, documentation, and the handling of inadequate attempts without judgement.

For remote services, pair the standard with transport reality. A pre-labelled kit, a collection window tied to courier runs, and a clear escalation route for a failed attempt can prevent storage and travel from becoming the real cause. In services supporting Aboriginal communities, design the instructions with local clinicians and community workers so the method respects privacy, language, and the practical distance patients may need to travel.

Build a lean flow from request to result

Map the flow from referral to result: request, preparation, collection, labelling, transport, accession, smear preparation, microscopy, authorisation, and feedback to the collector. At every handover, name the person or role who owns the next action. Use a visual board or simple electronic queue rather than parallel spreadsheets, and keep one specimen identifier unchanged through each stage. Pre-stage supplies and analyse specimens in arrival order unless clinical urgency justifies an exception.

Create a rapid loop for inadequate specimens. When a collector receives a rejection reason, they should know whether the next action is better technique, another attempt at the same site, an alternate specimen pathway, or clinical review. Codify this in the laboratory information system or paper form. Consistent feedback is essential because upstream improvement is unlikely when the collection team never learns why a specimen was repeated.

Control supplies, equipment and records

Standardise the materials that shape collection quality. Specify an approved sputum container and leak-resistant transport pouch for each service setting, then manage stock through minimum levels, expiry checks, and first-in-first-out rotation. Australian procurement teams can compare fit-for-purpose kits available through local suppliers and public tender processes rather than allowing each clinic to improvise. Check microscopes, stains, slide holders, and transport equipment against maintenance and quality-control schedules.

Keep documentation lean but sufficient. A single collection form can carry patient identifiers, specimen details, observed adequacy, rejection reason, collector, and transport time without duplicating clinical notes. Protect health information under Australian privacy obligations, restrict access, and remove identifiable details from improvement charts. Review forms during the pilot and eliminate fields that do not support a decision or regulatory requirement.

Align the method with GLI quality systems

Enter the improvement work in the GLI Quality Tool's four phases. During assessment, record the baseline and gaps; during planning, assign owners, measures, and required resources; during implementation, test the revised standard; during monitoring, review results and decide whether to standardise, adapt, or stop. Map each change to the relevant Quality Systems Essentials. Collection technique connects with personnel training, procedures, and documentation; transport controls connect with safety and equipment; rejection codes support assessment and data review; and regular review drives continual improvement. The phase checklists, user instructions, and downloadable materials can provide evidence for management review, particularly where NPAAC accreditation and AS/NZS ISO 15189 expectations require controlled processes.

Address retention and safe movement early. For specimens or processed material kept for TB retrospective analysis, define labelled storage locations, temperature conditions, access permissions, and disposal dates. The GLI's sample storage guidance can help teams design this supporting system. Confirm biosecurity, transport, and import conditions for any cross-border material; do not treat ordinary couriers as an automatic route for diagnostic specimens.

Measure the change through a controlled pilot

Pilot the method at one collection site for four weeks while leaving routine clinical decisions unchanged. Establish the baseline, then test a small bundle comprising the standard script, trained collectors, approved kits, rejection codes, and timely feedback. Track first-pass acceptable sputum, inadequate-specimen rate, documented repeat reasons, turnaround time, stockouts, mismatches, staff time, and patient return visits. Use run charts to distinguish genuine improvement from normal variation.

Review results weekly with collectors, laboratory scientists, transport staff, and a clinician. Check whether the process has shifted a problem downstream, because faster collection can create a reception bottleneck and stricter rejection can increase workload. Invite participating sites to use the GLI's structured feedback process to record what worked and what needs adjustment. After the pilot, revise the standard work and training, then connect the method to induction, competency assessment, quality meetings, and corrective-action processes.

Turn evidence into routine action

Select one collection site, appoint a named owner, download the relevant GLI checklist, and start the four-week baseline this week. Set the aim as reliable specimen collection with fewer avoidable repeat smears, while every clinically requested test remains visible.

Review the run chart at the next quality meeting, approve revised standard work, schedule competency and supply checks, and use the GLI monitoring phase to keep the cycle active. Make the tested collection method the default, audit it monthly, and record the result in the GLI monitoring phase.